Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

This publication has 40 references indexed in Scilit:

• Building an Outcome Predictor Model for Diffuse Large B-Cell Lymphoma
  The American Journal of Pathology, 2004
• Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
  Blood, 2004
• A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
  Proceedings of the National Academy of Sciences, 2003
• Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
  Blood, 2003
• Chromosomal Imbalances in Diffuse Large B-Cell Lymphoma Detected by Comparative Genomic Hybridization
  Laboratory Investigation, 2002
• The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
  New England Journal of Medicine, 2002
• Diffuse large cell lymphoma
  Current Opinion in Oncology, 2001
• Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry
  Laboratory Investigation, 2001
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
  Nature, 2000
• BCL2 Overexpression in Diffuse Large B-Cell Lymphoma
  Leukemia & Lymphoma, 1999